Glide has successfully completed an MHRA inspection held at its offices in Milton Park, Oxfordshire. The inspection covered the two clinical studies conducted by Glide for Fentanyl and Octreotide in 2009 and 2010 respectively. The inspection found no critical and no major findings related to either clinical study.
